New anticoagulant drugs

被引:125
作者
Weitz, JI
Hirsh, J
机构
关键词
D O I
10.1378/chest.119.1_suppl.95S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:95S / 107S
页数:13
相关论文
共 149 条
[1]  
Altman R, 1998, HAEMOSTASIS, V28, P229
[2]   Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial [J].
Antman, EM .
CIRCULATION, 1996, 94 (05) :911-921
[3]  
AOKI Y, 1994, THROMB HAEMOSTASIS, V71, P452
[4]   Bothrojaracin: A potent two-site-directed thrombin inhibitor [J].
Arocas, V ;
Zingali, RB ;
Guillin, MC ;
Bon, C ;
JandrotPerrus, M .
BIOCHEMISTRY, 1996, 35 (28) :9083-9089
[5]  
BAGDY D, 1992, THROMB HAEMOSTASIS, V67, P357
[6]  
BAJAJ SP, 1985, J BIOL CHEM, V260, P1574
[7]   HIGHLY-ACTIVE AND SELECTIVE ANTICOAGULANTS - D-PHE-PRO-ARG-H, A FREE TRIPEPTIDE ALDEHYDE PRONE TO SPONTANEOUS INACTIVATION, AND ITS STABLE N-METHYL DERIVATIVE, D-MEPHE-PRO-ARG-H [J].
BAJUSZ, S ;
SZELL, E ;
BAGDY, D ;
BARABAS, E ;
HORVATH, G ;
DIOSZEGI, M ;
FITTLER, Z ;
SZABO, G ;
JUHASZ, A ;
TOMORI, E ;
SZILAGYI, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1729-1735
[8]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[9]  
BASKOVA IP, 1991, BLOOD COAGUL FIBRIN, V2, P167
[10]  
Bata I, 1997, CIRCULATION, V96, P769